OptiNose

$4.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.23%) Today

+$0.07 (+1.64%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell OptiNose and other stocks, options, and ETFs commission-free!

About OPTN

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA. The listed name for OPTN is OptiNose, Inc. Common Stock.

CEO

Peter Kaighn Miller

Employees

224

Headquarters

Yardley, Pennsylvania

Founded

2000

Market Cap

222.38M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

600.56K

High Today

$4.35

Low Today

$4.15

Open Price

$4.22

Volume

280.19K

52 Week High

$10.07

52 Week Low

$3.14

Collections

OPTN Earnings

-$0.74

-$0.49

-$0.25

$0.00

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 4, Pre-Market